Bone Marrow Transplant UP

Bone Marrow Transplant in Uttar Pradesh — Advanced BMT Care at Jigyasa Hospital Moradabad

For patients across Uttar Pradesh dealing with blood cancers, bone marrow failure, or severe inherited blood disorders, bone marrow transplant is often the only treatment that offers a real chance at a cure. Until recently, accessing this life-saving procedure meant long, expensive journeys to major metro cities, out of reach for many families in western Uttar Pradesh.

Jigyasa Hospital, Moradabad is changing that. With Dr. Faran Naim, a dedicated specialist in hematology and bone marrow transplant, now practicing at Jigyasa Hospital, patients from Moradabad, Rampur, Sambhal, Amroha, Bareilly, Bijnor, and across the Rohilkhand and western Uttar Pradesh region can access BMT consultations, pre-transplant evaluation, and hematology-led care closer to home.

This page explains what bone marrow transplant is, the types of transplants, conditions where BMT is used, the transplant process, who may be a good candidate, and why consulting Dr. Faran Naim at Jigyasa Hospital can be an important step in planning the right treatment.

What Is Bone Marrow Transplant?

Bone marrow transplant, also called hematopoietic stem cell transplant, is a medical procedure that replaces diseased, damaged, or non-functioning bone marrow with healthy stem cells. These stem cells go on to produce healthy red blood cells, white blood cells, and platelets, restoring the blood system from the ground up.

The bone marrow is a spongy tissue found inside larger bones such as the hip and thigh bones and acts as the body's blood cell factory. When disease, whether due to cancer, autoimmune attack, or inherited genetic defect, disrupts this factory, the entire body is affected. Blood cannot carry enough oxygen, the immune system struggles to fight infections, and bleeding can become difficult to control.

Bone marrow transplant addresses the problem at its root. Rather than merely managing symptoms, a successful transplant can reset the blood system entirely and, in many cases, offer the possibility of complete cure.

Types of Bone Marrow Transplant

The choice of transplant type depends on the patient's diagnosis, disease stage, age, and donor availability. Dr. Faran Naim evaluates each case individually to determine the safest and most effective strategy.

Autologous Bone Marrow Transplant

In an autologous transplant, the patient's own stem cells are collected, stored, and then returned to the body after high-dose chemotherapy is given to eliminate the cancer. Because the stem cells come from the patient's own body, there is no risk of immune rejection.

Autologous transplant is commonly used in multiple myeloma, Hodgkin and non-Hodgkin lymphoma, and selected cases of acute myeloid leukemia.

Allogeneic Bone Marrow Transplant

In an allogeneic transplant, stem cells come from a healthy donor whose tissue type matches the patient as closely as possible. This is a more complex procedure and requires careful donor selection and post-transplant immunosuppression.

Allogeneic transplant is the standard of care in severe aplastic anemia, high-risk or relapsed acute leukemias, chronic myeloid leukemia in blast crisis, myelodysplastic syndromes, thalassemia major, selected sickle cell disease cases, and other inherited bone marrow failure syndromes.

Haploidentical (Half-Matched) Transplant

Haploidentical transplant uses a parent, child, or sibling who shares only half of the HLA markers. Advances in transplant medicine have made haploidentical procedures increasingly safe and effective, dramatically expanding the donor pool for patients who do not have a fully matched sibling or unrelated donor.

Conditions Treated with Bone Marrow Transplant

At Jigyasa Hospital, Dr. Faran Naim evaluates patients for bone marrow transplant across a wide range of serious blood conditions where BMT offers cure or significant survival benefit.

Blood Cancers

Acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma are among the blood cancers where transplant may be recommended in high-risk, relapsed, or selected settings.

Bone Marrow Failure Syndromes

Severe aplastic anemia, higher-risk myelodysplastic syndromes, and selected cases of pure red cell aplasia are examples of bone marrow failure conditions where allogeneic transplant can provide durable recovery or cure.

The Bone Marrow Transplant Process — What to Expect

Understanding the bone marrow transplant journey helps patients and families prepare for each stage. The hematology team at Jigyasa Hospital guides patients step by step, from initial evaluation through long-term follow-up.

Step 1: Pre-Transplant Evaluation

A comprehensive evaluation is performed, including review of the diagnosis, disease stage, prior treatments, organ function tests, infectious disease screening, bone marrow biopsy and molecular testing, HLA typing, and psychological and nutritional assessment. This determines transplant fitness and the most appropriate type of transplant.

Step 2: Donor Selection and HLA Matching

For allogeneic transplant, donor selection is critical. HLA matching between patient and donor helps reduce the risk of graft failure and graft-versus-host disease. Matched sibling donors are preferred, followed by matched unrelated donors or haploidentical family donors when needed.

Step 3: Conditioning Regimen

Before transplant, the patient receives a conditioning regimen, usually high-dose chemotherapy and sometimes radiation. This treatment aims to destroy diseased marrow and remaining cancer cells and to suppress the immune system so the new cells can engraft.

Step 4: Stem Cell Infusion (Day 0)

On transplant day, healthy stem cells are infused through a central venous line in a procedure that looks similar to a blood transfusion. The cells then travel to the bone marrow spaces, where they begin to establish a new blood-forming system.

Step 5: Engraftment Period

During the two to four weeks after infusion, blood counts fall to very low levels and patients are closely monitored for infection and bleeding. Supportive care includes antibiotics, antifungals, antivirals, blood and platelet transfusions, and sometimes growth factors until neutrophil counts recover and engraftment is confirmed.

Step 6: Post-Transplant Monitoring and GvHD Management

After engraftment, attention shifts to graft-versus-host disease, infection surveillance, and long-term recovery. The immune system remains suppressed for months, and most patients require close medical supervision for at least the first 100 days, with gradual return to normal activities over six to twelve months.

Who Is a Candidate for Bone Marrow Transplant?

Not every patient with a blood disorder requires bone marrow transplant. Suitability depends on the specific diagnosis, transplant risk–benefit balance, overall health, and donor availability. Each case is evaluated individually before transplant is recommended.

General considerations include a diagnosis for which transplant offers cure or clear survival benefit, adequate heart, lung, liver, and kidney function, age and physical fitness that match the intensity of conditioning, availability of a suitable donor for allogeneic transplant, and preparedness of the patient and family for the demands of the transplant journey.

The decision to proceed with transplant is always made after detailed discussion of all options. Dr. Faran Naim explains the benefits, risks, and alternatives so that patients and families can make an informed choice.

Diseases Where BMT Offers Cure — Not Just Control

For some conditions, bone marrow transplant is not just another treatment option but the only pathway to cure. Early evaluation is crucial to avoid missing the ideal window for transplant.

In thalassemia major, children without transplant face lifelong transfusions, iron overload, and organ damage. With a successful allogeneic transplant, especially when performed early in life, many children can achieve transfusion independence and lead normal lives.

In severe aplastic anemia with a matched sibling donor, prompt transplant offers long-term survival rates that are significantly higher than with medical therapy alone. Similarly, in selected high-risk or relapsed acute leukemias and severe sickle cell disease, transplant can transform long-term outcomes.

Timely referral to a hematologist experienced in transplant assessment helps ensure that patients are evaluated before disease progression or complications make transplant more difficult or risky.

Why Choose Dr. Faran Naim and Jigyasa Hospital for BMT in Uttar Pradesh

Jigyasa Hospital brings dedicated hematology and transplant expertise to the heart of western Uttar Pradesh. Dr. Faran Naim's subspecialty training in clinical hematology and bone marrow transplant, usually concentrated in large metro centres, is now accessible for patients in and around Moradabad.

The hospital supports comprehensive pre-transplant evaluation, including diagnostic confirmation, organ function assessment, HLA typing, and donor evaluation. Transplant care is multidisciplinary, involving hematologists, transfusion medicine, microbiology, dietetics, and experienced nursing staff working together for each patient.

Transparent communication is central to care. Bone marrow transplant discussions can be overwhelming, so consultations focus on clear explanations of diagnosis, treatment options, realistic outcomes, and the day-to-day realities of the transplant journey in language families can understand.

Patients who may be eligible for support under government schemes such as Ayushman Bharat, the Chief Minister's Relief Fund, or the Prime Minister's Relief Fund for blood disorder treatment are encouraged to discuss this with the Jigyasa Hospital team during their visit.

Patient Experiences

Frequently Asked Questions — Bone Marrow Transplant in Uttar Pradesh